🇺🇸 The U.S. Cell and Gene Therapy Third-Party Logistics (3PL) Market is projected to grow from US$2.61 billion in 2024 to US$5.88 billion by 2033, expanding at a strong CAGR of 9.46% 📈
Growing adoption of advanced cell and gene therapies across the healthcare sector
🔗 Read full report: 👉 https://www.renub.com/us-cell-....gene-therapy-third-p
📊 #celltherapy #genetherapy #biopharmalogistics #coldchain #healthcareinnovation #pharmasupplychain #3pl #biotech #ustherapymarket #renubresearch